ZERBATO BARBARA

Zerbato, B., Brancato, V., Gobbi, M., Pessina, A., Brambilla, L., Wegner, A., et al. (2024). Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy. Intervento presentato a: BtBs Day 2024, Milan, Italy. Dettaglio

Zerbato, B., Brancato, V., Gobbi, M., Pessina, A., Brambilla, L., Wegner, A., et al. (2024). Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy. Intervento presentato a: FEBS YSF 2024, Pavia, Italy. Dettaglio

Zerbato, B., Brancato, V., Gobbi, M., Pessina, A., Brambilla, L., Wegner, A., et al. (2024). Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy. Intervento presentato a: FEBS 2024, Milan, Italy. Dettaglio

Zerbato, B., Gobbi, M., Ludwig, T., Brancato, V., Pessina, A., Brambilla, L., et al. (2024). PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response. Intervento presentato a: 1st Italian Pancreatic Cancer Symposium (IPCC), Padua, Italy. Dettaglio

Venturi, S., Chiaradonna, F., Gatti, F., La Ferla, B., Parolini, R., Zerbato, B. (2024). Chiral trimethyl lock based on vicinal disubstituent effect: prolonged release of Camptothecin into cancer cells. CHEMICAL COMMUNICATIONS, 60(51), 6524-6527 [10.1039/d4cc01220h]. Dettaglio